Gene marker study for surgical site infections
Part of Infections clinical trials.
This study looks at bacteria that cause infections after surgery to understand why some are resistant to antibiotics. Your participation could help doctors find better ways to treat these infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery and developed an infection at the surgical site.
- A sample from your infection has been collected and tested.
- You are willing to allow researchers to study that sample.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special DNA test (called next-generation sequencing) can help doctors better identify and treat bone infections after fracture surgery. It compares this test to the usual culture method to see if it leads to better outcomes with antibiotics.
This study is building a tool to predict the risk of surgical site infection after brain or spinal tumor surgery. It may help you understand your personal infection risk before your procedure.
This Phase 3 study tests whether giving a broad set of preventive antibiotics before certain high-risk orthopedic surgeries lowers the chance of serious wound or bone infection. It mainly targets people who have contaminated wounds, tumor-related surgery, or known high-risk germs on the skin.
This trial tests if a simple at-home treatment (using a nasal ointment and special body wash) before surgery can prevent staph infections at the surgical site. It's for adults having outpatient surgery in several specialties, like orthopedics or general surgery.
This study tests different combinations of antibiotics to treat a staph infection in the blood. If you're in an Intermountain hospital with this infection, the trial may help doctors find the most effective treatment for you.
This trial tests the best treatment approach for bloodstream infections caused by Staphylococcus aureus (“S. aureus”). It uses a flexible design to decide which treatment track you fit into, and may help improve recovery while avoiding unnecessary medications.
Hear when a new Staphylococcal Aureus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.